Mednet Logo

How does the finding of incidental proximal seminal vesicle invasion on mpMRI alter your recommendation for brachytherapy in a patient with prostate cancer who was initially a candidate?

cT3 patients were a minority of patients in the data demonstrating superiority of tri-modality therapy. While cT3b patients have particularly poor outcomes, an incidental finding of cT3b disease may portend a better prognosis. Would you 1. continue to plan for an implant? 2. How would you specifically approach implanting this patient? Would you avoid a Mick based loose seed technique in the vesicular structures and use pre-loaded needles? 3. What dosimetric parameters do you use to evaluate seminal vesicle coverage?
Community PollStarted

How does the finding of incidental SV invasion on mpMRI alter your recommendation for brachytherapy in a patient with prostate cancer who was initially a candidate?

72 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · NYU Langone
Answered on

An additional thought...........

Regarding this question as well we need to be cautious about the word "incidental". Normally an "incidental" finding would be characterized as a patient who was undergoing a CT scan of the abdomen and pelvis for the workup of a high grade prostate cancer, for instanc...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · NYU Langone
Answered on

The MRI finding of proximal seminal vesicle invasion in a patient who is thought to have earlier stage disease based on clinical exam and other parameters is not that unusual of a clinical scenario. Often, such situations are observed among patients who have a larger volume of disease at the base wi...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · CoxHealth Radiation Oncology
Answered on

Based on the recent ASCEDE-RT trial and many other retrospective studies, we combine EBRT and permanent seed implant for these patient. Using preloaded stranded seeds, especially the newer strands which tend NOT to migrate, does cover the target area.

In addition, based other prognostic features (PSA...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Oakland University William Beaumont School of Medicine
Answered on

The comments above are 100% on the nose. Re-evaluation of the case as regards to other clinical factors is certainly warranted.

ASCENDE is the trial of note here with a roughly 50% relative reduction in PSA failure with addition of brachytherapy boost with 12 months of androgen deprivation and extern...

Join for free or sign in to see the full answer